INmune Bio Inc
Financing
SEC filings to 2026-10-05 · every row opens its filingShares on issue
27.7M
on 2026-06-30, from 18.0M on 2024-03-31 10-Q ↗
a raise that quarter, at its price
Newest
S-3 of 2024-05-01. Not read yet. S-3 ↗
14 of its filings are not read yet.
Cash
4.9 quarters
$18.4M on 2026-06-30 ÷ $3.7M a quarter of operating cash used, the average of four quarters. 10-Q ↗
| Date | What | Shares | Price | Gross | Filing |
|---|---|---|---|---|---|
| 2025-12-19 | Public offering | not read | not read | not read | 424B5 ↗ |
| 2025-06-30 | Public offering | 3,000,000 | $6.30 | $18.9M | 424B5 ↗ |
| 2025-03-07 | Registered direct offering | not read | $9.152 | $5.2M | 424B5 ↗ |